Qingzhi Wu, NP
Nurse Practitioner · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Quality Care Solution Inc · 12 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Qingzhi Wu’s office at (832) 618-8479 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$957,347
Medicare paid this office $957,347 for 482 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 460 | $543,203 | $84 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 420 | $317,188 | $59 |
| Nursing facility discharge management, more than 30 minutes | 291 | $37,905 | $101 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 248 | $36,364 | $119 |
| Advance care planning, first 30 minutes | 184 | $22,242 | $64 |
Who their Medicare patients are
482 Original Medicare patients in 2024. Average age 78 · Under 65 10% · 85 and older 32% · Women 57% · Also on Medicaid 69% · Health risk score 3.00. Sicker patients than 9 in 10 peers; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Dementia 61% · Depression 60% · Diabetes 51% · Coronary heart disease 45% · Heart failure 40% · Chronic kidney disease 38% · Atrial fibrillation 35% · COPD 33% · Stroke 29% · Cancer 16%.
The office billed $2,312,720, Medicare allowed $1,205,900 and paid $957,347; for 12,880 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 482 | 12,880 | 78 | 3.00 | $2,312,720 | $957,347 |
| 2023 | 548 | 12,440 | 80 | 2.92 | $2,260,460 | $933,143 |
| 2022 | 387 | 6,079 | 79 | 2.09 | $1,112,555 | $402,668 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 531 | $541,618 | $83 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 444 | $248,641 | $58 |
| Advance care planning, first 30 minutes | 374 | $57,464 | $65 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 350 | $50,728 | $119 |
| Nursing facility discharge management, more than 30 minutes | 270 | $34,082 | $101 |
2022: 4 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 366 | $251,777 | $71 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 294 | $111,843 | $54 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 195 | $22,803 | $103 |
| Advance care planning, first 30 minutes | 133 | $14,890 | $67 |
Medicaid work
$9,957 in 2024
Medicaid paid $9,957 for 4,450 billed services this clinician did in 2024, up to 89 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 2,236 | $6,743 |
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 1,998 | $2,277 |
| Advance care planning including the explanation and discussion of advance directives such as standard forms (with completion of such forms, when performed), by the physician or other qualified health care professional; first 30 minutes, face-to-face with the patient, family member(s), and/or surrogate | 102 | $488 |
| Nursing facility discharge management; more than 30 minutes total time on the date of the encounter | 71 | $347 |
| SBSQ NURSING FACILITY CARE HIGH MDM 45 MINUTES | 43 | $104 |
| 2024 | 4,450 | 5 | 89 | $9,957 |
| 2023 | 4,900 | 5 | 107 | $10,923 |
| 2022 | 2,489 | 2 | 70 | $2,103 |
See the largest Medicaid services in earlier years
2023
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 2,472 | $6,321 |
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 2,030 | $2,904 |
| SBSQ NURSING FACILITY CARE HIGH MDM 45 MINUTES | 67 | $937 |
| Advance care planning including the explanation and discussion of advance directives such as standard forms (with completion of such forms, when performed), by the physician or other qualified health care professional; first 30 minutes, face-to-face with the patient, family member(s), and/or surrogate | 303 | $761 |
| Nursing facility discharge management; more than 30 minutes total time on the date of the encounter | 28 | $0 |
2022
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 1,468 | $1,640 |
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 1,021 | $463 |
Drugs they prescribed that Part D paid
$38,865
Pharmacies billed $38,865 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 34% of their Part D prescriptions (189 of 554) in 2024. A higher opioid share than 9 in 10 peers; the typical nurse practitioner clinician is at 0%. Long-acting opioids: 14% of their opioid prescriptions.
413 generic and 141 brand-name prescriptions · $38,865 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lacosamide | 36 | $16,379 | $455 |
| Fentanyl | 16 | $2,388 | $149 |
| Oxycodone | 47 | $1,959 | $42 |
| Lorazepam | 52 | $1,259 | $24 |
| Oxycodone-Acetaminophen | 33 | $1,063 | $32 |
See all 14 drugs
| Lacosamide | 36 | $16,379 | $455 |
| Fentanyl | 16 | $2,388 | $149 |
| Oxycodone | 47 | $1,959 | $42 |
| Lorazepam | 52 | $1,259 | $24 |
| Oxycodone-Acetaminophen | 33 | $1,063 | $32 |
| Hydrocodone-Acetaminophen | 43 | $881 | $20 |
| Levothyroxine | 42 | $468 | $11 |
| Potassium Chloride | 48 | $453 | $9 |
| Morphine Sulfate | 29 | $364 | $13 |
| Clonazepam | 16 | $240 | $15 |
| Duloxetine | 11 | $229 | $21 |
| Atorvastatin | 13 | $179 | $14 |
| Metoprolol | 12 | $151 | $13 |
| Ondansetron | 14 | $52 | $4 |
Year by year
| 2024 | 554 | 85 | 34% (189) | 25% | $38,865 |
| 2023 | 440 | 67 | 31% (138) | None | $38,315 |
| 2022 | 82 | 29 | 27% (22) | None | $2,420 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Lacosamide | 35 | $15,006 | $429 |
| Fentanyl | 19 | $3,589 | $189 |
| Oxycontin | 21 | $3,205 | $153 |
| Permethrin | 15 | $1,206 | $80 |
| Levetiracetam | 18 | $1,205 | $67 |
| Oxycodone | 38 | $969 | $25 |
| Pregabalin | 15 | $690 | $46 |
| Morphine Sulfate | 16 | $494 | $31 |
| Hydrocodone-Acetaminophen | 34 | $472 | $14 |
| Lorazepam | 38 | $386 | $10 |
| Ondansetron | 17 | $225 | $13 |
| Levothyroxine | 19 | $197 | $10 |
| Gabapentin | 13 | $149 | $11 |
| Trazodone | 12 | $105 | $9 |
2022: 1 drug
| Losartan | 26 | $138 | $5 |
Money from drug and device companies
$124 in 2025
| 2025 | 1 | 1 | None | $124 |
| 2024 | 3 | 4 | None | $366 |
| 2023 | 4 | 4 | None | $475 |
| 2022 | 5 | 6 | None | $734 |
| 2021 | 3 | 3 | None | $359 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Neurocrine BioSciences | Ingrezza | $124 | 1 payment
|
See the published payment
| Neurocrine BioSciences | Meals · 2025-03-13 | Ingrezza | $124 |
See earlier years (2024, 2023, 2022, 2021)
2024: $366
| AstraZeneca Pharmaceuticals LP | None | $126 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $125 | 2 payments
|
| GlaxoSmithKline | None | $115 | 1 payment
|
2023: $475
| Neurocrine Biosciences | Ingrezza | $125 | 1 payment
|
| Genzyme | Dupixent | $123 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo | $118 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $110 | 1 payment
|
2022: $734
| Abbvie | Skyrizi | $240 | 2 payments
|
| Novo Nordisk | Saxenda | $125 | 1 payment
|
| Amgen | Repatha | $125 | 1 payment
|
| AVEO Pharmaceuticals | Fotivda | $125 | 1 payment
|
| Genentech USA | Ocrevus | $119 | 1 payment
|
2021: $359
| Bayer HealthCare Pharmaceuticals | Kerendia | $125 | 1 payment
|
| Amgen | Kyprolis | $125 | 1 payment
|
| Celgene | Reblozyl | $109 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 21.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1144982935
- Licence
- CA NP95018255
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X); Federal specialty code 363LA2100X (363LA2100X)
- Mailing address
- 19930 Wright Dr, Los Gatos, CA, 95033
- NPI first listed
- 2021-10-08
- NPI last updated
- 2024-02-10
- NPI record certified
- 2024-02-10
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 19930 Wright Dr, Los Gatos, CA, 95033